111 related articles for article (PubMed ID: 26716947)
1. The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1.
Hailfinger S; Schmitt A; Schulze-Osthoff K
FEBS J; 2016 Feb; 283(3):400-2. PubMed ID: 26716947
[No Abstract] [Full Text] [Related]
2. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
[TBL] [Abstract][Full Text] [Related]
3. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
Douanne T; Gavard J; Bidère N
J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
[TBL] [Abstract][Full Text] [Related]
4. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
[TBL] [Abstract][Full Text] [Related]
5. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
[TBL] [Abstract][Full Text] [Related]
6. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
7. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
Zhou H; Du MQ; Dixit VM
Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263
[TBL] [Abstract][Full Text] [Related]
8. Regulation of NF-κB signaling by caspases and MALT1 paracaspase.
Staal J; Bekaert T; Beyaert R
Cell Res; 2011 Jan; 21(1):40-54. PubMed ID: 21119681
[TBL] [Abstract][Full Text] [Related]
9. Probes to monitor activity of the paracaspase MALT1.
Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
[TBL] [Abstract][Full Text] [Related]
10. The Paracaspase MALT1.
Hachmann J; Salvesen GS
Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
[TBL] [Abstract][Full Text] [Related]
11. Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system.
Sasaki K; Iwai K
Immunol Rev; 2015 Jul; 266(1):175-89. PubMed ID: 26085215
[TBL] [Abstract][Full Text] [Related]
12. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM
Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
Lynch OT; Gadina M
Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
Fontán L; Melnick A
Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
[TBL] [Abstract][Full Text] [Related]
15. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
Ruefli-Brasse AA; French DM; Dixit VM
Science; 2003 Nov; 302(5650):1581-4. PubMed ID: 14576442
[TBL] [Abstract][Full Text] [Related]
16. Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.
Rozmus J; McDonald R; Fung SY; Del Bel KL; Roden J; Senger C; Schultz KR; McKinnon ML; Davis J; Turvey SE
Clin Immunol; 2016 Jul; 168():1-5. PubMed ID: 27109639
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
[TBL] [Abstract][Full Text] [Related]
18. Dissection of signaling in inflammation: three novel inflammatory regulators.
Berger T; Saunders ME; Mak TW
Cold Spring Harb Symp Quant Biol; 2013; 78():141-7. PubMed ID: 25028400
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear factor-kappa B by linear ubiquitin chain assembly complex contributes to lung metastasis of osteosarcoma cells.
Tomonaga M; Hashimoto N; Tokunaga F; Onishi M; Myoui A; Yoshikawa H; Iwai K
Int J Oncol; 2012 Feb; 40(2):409-17. PubMed ID: 21947385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
